Everyone's Chasing Health Systems. The Smart Money Isn't.

Why this issue exists

Ask most digital health founders who they're targeting and you'll hear the same list. Academic medical centers. Large integrated delivery networks. National health systems.

It makes sense. They're recognizable. They're prestigious. They're exactly where almost every startup is competing for the same meeting.

What you don't hear enough about is another buyer quietly reshaping the digital health landscape: large, independently owned, multi-specialty physician groups.

These organizations may have 20 to 75 physicians, multiple specialties, imaging, laboratory services, ambulatory surgery, and participation in value-based care arrangements. They're sophisticated enough to purchase enterprise technology, yet agile enough to make decisions without nine layers of committees.

They may also represent one of the greatest untapped commercial opportunities in healthcare.

Curb moment: Everyone wants the logo. Few people are chasing the customer.

The Primary Signal: The Market Everyone Forgot

Recent conversations with executive leaders from several independent physician groups revealed something remarkably consistent. These organizations are actively looking for solutions that help them:

Improve operational efficiency

Reduce administrative burden

Strengthen financial performance

Compete with larger health systems

Deliver a better patient experience

But here's the signal most founders miss: they don't have innovation budgets.

Unlike large academic health systems, independent physician groups rarely have dedicated funds set aside to "experiment" with new technology. Every purchase competes against operational priorities — hiring another nurse, replacing aging equipment, expanding clinic hours, upgrading imaging.

Technology isn't funded because it's innovative. It's funded because it solves a business problem.

That shifts the burden to the startup. Not to explain what the technology does… but to prove why it's worth paying for.

Commercial Signal: If your business case depends on an innovation budget, you're selling into the wrong economic reality.

The Buying Signal: You're Probably Calling the Wrong Person

One of the biggest commercial mistakes founders make? Assuming physicians buy technology. Most don't.

Across independent physician groups, new technology is typically evaluated first by operational leadership: Chief Administrative Officers, Practice Administrators, Executive Directors, and CEOs.

Their job isn't to buy software. Their job is to protect the organization from unnecessary risk and disruption. They evaluate operational impact, financial return, workflow disruption, vendor credibility, and implementation complexity. Only after those questions are answered do physicians usually become involved.

Trying to bypass administration rarely speeds up the sale. More often, it slows it down.

Curb moment: Don't confuse the clinical champion with the economic buyer.

Digital Health Moves at the Speed of Trust

Perhaps the strongest signal from every conversation was this: the strength of the relationship is often more important than the strength of the technology.

Think about that. Healthcare leaders are not simply buying software. They're buying confidence. Confidence that you'll implement successfully. Confidence you'll support their staff. Confidence you'll answer the phone six months after the contract is signed.

Warm introductions consistently outperform cold outreach because trust has already begun before the first meeting. Relationships reduce uncertainty. Technology alone does not.

In healthcare, trust isn't a soft skill. It's a commercial strategy.

Curb moment: A great relationship can earn a second meeting. A great demo rarely earns a second chance.

The ROI Burden

This may be the biggest commercial lesson of all. Independent physician groups don't have the luxury of experimenting. Every technology purchase has to answer one question: "What happens if we don't buy this?"

Can it increase revenue? Reduce costs? Save physician time? Improve patient access? Reduce staff burnout? Lower denials? Improve quality scores?

If those answers aren't measurable, the decision becomes easy. The answer is no.

The burden of proof has shifted. It no longer belongs to the buyer. It belongs to the seller.

Commercial Guidance: Winning This Market

If you're selling into independent physician groups, five signals stood out.

1. Build relationships before building pipeline. Healthcare is still a relationship business. Warm introductions consistently outperform cold outreach because credibility travels faster than email.

2. Diagnose before you demonstrate. Don't begin with your platform. Begin with their problems. Questions build trust. Features don't.

3. Respect the buying process. Administrative leaders aren't gatekeepers. They're protecting physician time, organizational resources, and financial performance. Treat them like strategic partners.

4. Carry the ROI burden. Don't ask buyers to imagine the value. Show it. Bring financial models, operational metrics, case studies, and implementation timelines. If you can't quantify the impact, expect the conversation to stall.

5. Go where these buyers gather. State MGMA meetings, specialty societies, and regional physician association conferences remain some of healthcare's most underappreciated sales opportunities. Less competition. Longer conversations. Better buyers.

Curb moment: Everyone goes to HIMSS. The smartest founders are building relationships where everyone else isn't.

SigCom Interpretation

Digital health has spent the last decade optimizing for health systems. The next decade may belong to companies that understand a different buyer.

Large independent physician groups are financially meaningful. Operationally agile. Commercially underserved. But they also represent a more disciplined customer — no innovation budget, little tolerance for disruption, high expectations for measurable outcomes. And above all… a buying process built on trust.

Technology may open the conversation. Relationships close the deal.

Sometimes the biggest competitive advantage isn't having better technology. It's becoming the company buyers trust enough to bet their practice on.

The Lab Note

If you're selling into independent physician groups — or leading one — I want to hear from you. What earns your trust? What's turning buyers away? And how has your purchasing process changed over the past two years?

No hype. No promotion. Just signals.